359 related articles for article (PubMed ID: 23129054)
1. A class of tricyclic compounds blocking malaria parasite oocyst development and transmission.
Eastman RT; Pattaradilokrat S; Raj DK; Dixit S; Deng B; Miura K; Yuan J; Tanaka TQ; Johnson RL; Jiang H; Huang R; Williamson KC; Lambert LE; Long C; Austin CP; Wu Y; Su XZ
Antimicrob Agents Chemother; 2013 Jan; 57(1):425-35. PubMed ID: 23129054
[TBL] [Abstract][Full Text] [Related]
2. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
[TBL] [Abstract][Full Text] [Related]
3. The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites.
Delves M; Plouffe D; Scheurer C; Meister S; Wittlin S; Winzeler EA; Sinden RE; Leroy D
PLoS Med; 2012 Feb; 9(2):e1001169. PubMed ID: 22363211
[TBL] [Abstract][Full Text] [Related]
4. Differential activity of methylene blue against erythrocytic and hepatic stages of Plasmodium.
Bosson-Vanga H; Franetich JF; Soulard V; Sossau D; Tefit M; Kane B; Vaillant JC; Borrmann S; Müller O; Dereuddre-Bosquet N; Le Grand R; Silvie O; Mazier D
Malar J; 2018 Apr; 17(1):143. PubMed ID: 29615050
[TBL] [Abstract][Full Text] [Related]
5. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria.
Biagini GA; Fisher N; Shone AE; Mubaraki MA; Srivastava A; Hill A; Antoine T; Warman AJ; Davies J; Pidathala C; Amewu RK; Leung SC; Sharma R; Gibbons P; Hong DW; Pacorel B; Lawrenson AS; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Stocks PA; Nixon GL; Chadwick J; Hemingway J; Delves MJ; Sinden RE; Zeeman AM; Kocken CH; Berry NG; O'Neill PM; Ward SA
Proc Natl Acad Sci U S A; 2012 May; 109(21):8298-303. PubMed ID: 22566611
[TBL] [Abstract][Full Text] [Related]
6. Mosquito ingestion of antibodies against mosquito midgut microbiota improves conversion of ookinetes to oocysts for Plasmodium falciparum, but not P. yoelii.
Noden BH; Vaughan JA; Pumpuni CB; Beier JC
Parasitol Int; 2011 Dec; 60(4):440-6. PubMed ID: 21763778
[TBL] [Abstract][Full Text] [Related]
7. Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit
Sosa Y; Deniskin R; Frame IJ; Steiginga MS; Bandyopadhyay D; Graybill TL; Kallal LA; Ouellette MT; Pope AJ; Widdowson KL; Young RJ; Akabas MH
ACS Infect Dis; 2019 Oct; 5(10):1738-1753. PubMed ID: 31373203
[TBL] [Abstract][Full Text] [Related]
8. Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity.
Vanaerschot M; Lucantoni L; Li T; Combrinck JM; Ruecker A; Kumar TRS; Rubiano K; Ferreira PE; Siciliano G; Gulati S; Henrich PP; Ng CL; Murithi JM; Corey VC; Duffy S; Lieberman OJ; Veiga MI; Sinden RE; Alano P; Delves MJ; Lee Sim K; Winzeler EA; Egan TJ; Hoffman SL; Avery VM; Fidock DA
Nat Microbiol; 2017 Oct; 2(10):1403-1414. PubMed ID: 28808258
[TBL] [Abstract][Full Text] [Related]
9. 4-(1H)-Quinolones and 1,2,3,4-Tetrahydroacridin-9(10H)-ones prevent the transmission of Plasmodium falciparum to Anopheles freeborni.
Sáenz FE; Lacrue AN; Cross RM; Maignan JR; Udenze KO; Manetsch R; Kyle DE
Antimicrob Agents Chemother; 2013 Dec; 57(12):6187-95. PubMed ID: 24080648
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Evaluation of Chirally Defined Side Chain Variants of 7-Chloro-4-Aminoquinoline To Overcome Drug Resistance in Malaria Chemotherapy.
Dola VR; Soni A; Agarwal P; Ahmad H; Raju KS; Rashid M; Wahajuddin M; Srivastava K; Haq W; Dwivedi AK; Puri SK; Katti SB
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956423
[TBL] [Abstract][Full Text] [Related]
11. Yeast-based high-throughput screen identifies Plasmodium falciparum equilibrative nucleoside transporter 1 inhibitors that kill malaria parasites.
Frame IJ; Deniskin R; Rinderspacher A; Katz F; Deng SX; Moir RD; Adjalley SH; Coburn-Flynn O; Fidock DA; Willis IM; Landry DW; Akabas MH
ACS Chem Biol; 2015 Mar; 10(3):775-83. PubMed ID: 25602169
[TBL] [Abstract][Full Text] [Related]
12. Effects of the antimalarial drugs ferroquine and artesunate on Plasmodium yoelii yoelii gametocytegenesis and vectorial transmission.
Mustfa K; Landau I; Chabaud AG; Chavatte JM; Chandenier J; Duong TH; Richard-Lenoble D
Sante; 2011; 21(3):133-42. PubMed ID: 22294247
[TBL] [Abstract][Full Text] [Related]
13. Identification of first-in-class plasmodium OTU inhibitors with potent anti-malarial activity.
Siyah P; Akgol S; Durdagi S; Kocabas F
Biochem J; 2021 Sep; 478(18):3445-3466. PubMed ID: 34486667
[TBL] [Abstract][Full Text] [Related]
14. Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination.
Abdul-Ghani R; Beier JC
Parasitol Res; 2014 Oct; 113(10):3535-46. PubMed ID: 25185662
[TBL] [Abstract][Full Text] [Related]
15. Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
Meister S; Plouffe DM; Kuhen KL; Bonamy GM; Wu T; Barnes SW; Bopp SE; Borboa R; Bright AT; Che J; Cohen S; Dharia NV; Gagaring K; Gettayacamin M; Gordon P; Groessl T; Kato N; Lee MC; McNamara CW; Fidock DA; Nagle A; Nam TG; Richmond W; Roland J; Rottmann M; Zhou B; Froissard P; Glynne RJ; Mazier D; Sattabongkot J; Schultz PG; Tuntland T; Walker JR; Zhou Y; Chatterjee A; Diagana TT; Winzeler EA
Science; 2011 Dec; 334(6061):1372-7. PubMed ID: 22096101
[TBL] [Abstract][Full Text] [Related]
16. Human dihydrofolate reductase influences the sensitivity of the malaria parasite Plasmodium falciparum to ketotifen - A cautionary tale in screening transgenic parasites.
Tran PN; Tate CJ; Ridgway MC; Saliba KJ; Kirk K; Maier AG
Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):179-183. PubMed ID: 27705841
[TBL] [Abstract][Full Text] [Related]
17. Targeting mosquito FREP1 with a fungal metabolite blocks malaria transmission.
Niu G; Wang B; Zhang G; King JB; Cichewicz RH; Li J
Sci Rep; 2015 Oct; 5():14694. PubMed ID: 26437882
[TBL] [Abstract][Full Text] [Related]
18. A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery.
Almela MJ; Lozano S; Lelièvre J; Colmenarejo G; Coterón JM; Rodrigues J; Gonzalez C; Herreros E
PLoS One; 2015; 10(8):e0135139. PubMed ID: 26317851
[TBL] [Abstract][Full Text] [Related]
19. Ketotifen is an antimalarial prodrug of norketotifen with blood schizonticidal and liver-stage efficacy.
Milner E; Sousa J; Pybus B; Auschwitz J; Caridha D; Gardner S; Grauer K; Harris E; Hickman M; Kozar MP; Lee P; Leed S; Li Q; Melendez V; Moon J; Ngundam F; O'Neil M; Parriott S; Potter B; Sciotti R; Tangteung A; Dow GS
Eur J Drug Metab Pharmacokinet; 2012 Mar; 37(1):17-22. PubMed ID: 22314893
[TBL] [Abstract][Full Text] [Related]
20. A high-throughput screen targeting malaria transmission stages opens new avenues for drug development.
Buchholz K; Burke TA; Williamson KC; Wiegand RC; Wirth DF; Marti M
J Infect Dis; 2011 May; 203(10):1445-53. PubMed ID: 21502082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
